Alert: Major Price Decline (9/3/24)-XBiotech Inc (NASDAQ: XBIT).

out_logo_500#72315.jpg

XBiotech Inc (NASDAQ: XBIT) stock suffered a major decline of -10.2% on 9/3/24. The shares closed at $5.75. However, trading volume in this decline was exceptionally low at 49% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -12.6% during the last week.

out_mm#72315.jpg

Current PriceTarget Research Rating

XBIT is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.

XBiotech has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. XBiotech has a poor Appreciation Score of 26 but a very high Power Rating of 85, and the Neutral Value Trend Rating results.

Rating Review

In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.


*